Literature DB >> 12098930

Components of the IFN-gamma signaling pathway in tumorigenesis.

George Blanck1.   

Abstract

Many features of the interferon gamma (IFN-gamma) signaling pathway would suggest that it is anti-tumorigenic. The IFN-gamma signaling pathway leads to apoptosis and to the expression of immune function proteins that could cooperate with T cells in the destruction of tumor. Various lines of experimental approach have, in general, supported the hypothesis that the IFN-gamma signaling pathway is anti-tumorigenic. However, data also indicate that the idea that the IFN-gamma signaling pathway is exclusively anti-tumorigenic is too simplistic. Also, to date, very little of the knowledge regarding the anti-tumor effects of the IFN-gamma pathway has been useful in the prognosis or therapy of cancer. This review summarizes the current state of knowledge regarding the IFN-gamma signaling pathway in tumorigenesis, with an emphasis on MHC class II induction in tumor cells and the induction of apoptosis in tumor cells. The review also indicates some future areas of investigation that offer hope for applying this knowledge in reducing cancer mortality.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098930

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  6 in total

1.  IFN-γ induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells: A novel mechanism for IFN-γ response.

Authors:  Guoping Ding; Liangjing Zhou; Tao Shen; Liping Cao
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

2.  MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.

Authors:  John M Yavorski; George Blanck
Journal:  Mol Clin Oncol       Date:  2017-09-29

3.  Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21.

Authors:  Hadiseh Samiei; Bizhan Sadighi-Moghaddam; Saeed Mohammadi; Abdolsamad Gharavi; Sara Abdolmaleki; Ayyoob Khosravi; Parviz Kokhaei; Hadi Bazzazi; Ali Memarian
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

4.  Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma.

Authors:  Joseph George; Naren L Banik; Swapan K Ray
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

5.  Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice.

Authors:  Cong-Mei Wu; Xiu-Yi Li; Tian-Hua Huang
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

6.  Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration.

Authors:  Michael R Strickland; Emily J Koller; Doris Z Deng; Carolina Ceballos-Diaz; Todd E Golde; Paramita Chakrabarty
Journal:  Neurobiol Dis       Date:  2017-11-28       Impact factor: 5.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.